In non-small cell lung cancer, in vitro experiments demonstrate that CXCL12 binding to CXCR4, via activation of the JAK2/STAT3 signaling pathway, reduces the proportion of lung cancer cell apoptosis induced by the chemotherapeutic drug cisplatin. This evidence concerns the gene CXCR4 and lung cancer.